New Parkinson's drug, safinamide, launched in UK
This week Zambon and Newron Pharmaceuticals launched a new Parkinson’s drug called safinamide (trade name Xadago®) in the UK.
What the Queen's Speech means for people with Parkinson's
The Queen set out the Government’s plans for new laws and its ongoing work for the coming year. We look at what this means for people with Parkinson's.
Reassurance for people with Parkinson's who drive
The majority of people with Parkinson's that tell the DVLA about their condition are getting their driving licence renewed for 3 years, new data shows.
Tell us how social care is working in England
Take our survey. We need your experiences of the social care system to help us make recommendations on improving access for people with Parkinson's.
First drug approved to treat hallucinations and delusions
On 29 May pimavanserin was approved by the US Food and Drug Administration as the first drug for treating hallucinations and delusions
Positive steps towards a blood test for Parkinson's
Research highlighted in the Guardian yesterday suggests that a blood test could be used to help detect Parkinson's.
People with Parkinson's forced to hide their condition
Research launched to mark Parkinson's Awareness Week reveals that many with Parkinson's have hidden their symptoms or lied about having the condition.
Out now: latest Parkinson's research magazine
The spring 2016 issue of Progress, our free research magazine, is out now.
New clue in the hunt for treatments that slow ageing
New research published today has identified a vital new target in the search for treatments that can slow ageing, and could one day prevent Parkinson's.
Help put Parkinson's on the election agenda
The elections in Northern Ireland, Scotland and Wales are your opportunity to engage with your local politicians on issues that are important to you.